Onconetix, Inc. (ONCO) stock
ONCONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.43−0.05 (-10.13%)
Close on Oct 19, 2026Market cap $965.06KP/E –Yield –
Onconetix shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Onconetix's shares outstanding was 2M at Jun 30, 2026. For fiscal 2025 it was 1M, up 2803.0% from the year before. The highest annual figure on record is 1M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1M | +2803.0% |
| FY2024 | Dec 31, 2024 | 0M | +541.8% |
| FY2023 | Dec 31, 2023 | 0M | +39.5% |
| FY2022 | Dec 31, 2022 | 0M | +283.5% |
| FY2021 | Dec 31, 2021 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 2M | +19654.9% |
| Q1 FY2026 | Mar 31, 2026 | 1M | +1370.1% |
| Q4 FY2025 | Dec 31, 2025 | 2M | +10107.4% |
| Q3 FY2025 | Sep 30, 2025 | 1M | +21429.9% |
| Q2 FY2025 | Jun 30, 2025 | 0M | +74.3% |
| Q1 FY2025 | Mar 31, 2025 | 0M | +661.4% |
| Q3 FY2024 | Sep 30, 2024 | 0M | +198.2% |
| Q2 FY2024 | Jun 30, 2024 | 0M | +36.7% |
| Q1 FY2024 | Mar 31, 2024 | 0M | +54.5% |
| Q4 FY2023 | Dec 31, 2023 | 0M | +59.2% |
| Q3 FY2023 | Sep 30, 2023 | 0M | +176.3% |
| Q4 FY2022 | Dec 31, 2022 | 0M | +407.5% |
| Q3 FY2022 | Sep 30, 2022 | 0M | +348.1% |
| Q2 FY2022 | Jun 30, 2022 | 0M | +274.9% |
| Q1 FY2022 | Mar 31, 2022 | 0M | – |
| Q4 FY2021 | Dec 31, 2021 | 0M | – |
| Q3 FY2021 | Sep 30, 2021 | 0M | – |
| Q2 FY2021 | Jun 30, 2021 | 0M | – |
See a number that looks wrong?